Patent · US Active

Nucleic acids encoding modified relaxin polypeptides

US9452222B2 · kind B2 · utility

15Cited by
187References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 10, 2014
Grant dateSep 27, 2016
Priority date—
Expiry dateJan 10, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Modified relaxin polypeptides and their uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.